NYSEArca - Delayed Quote USD

The Real Estate Select Sector SPDR Fund (XLRE)

41.83 +0.64 (+1.55%)
At close: August 1 at 4:00 PM EDT
41.75 -0.08 (-0.19%)
Pre-Market: 7:51 AM EDT
Loading Chart for XLRE
DELL
  • Previous Close 41.19
  • Open 41.62
  • Bid 41.33 x 21500
  • Ask 42.05 x 39400
  • Day's Range 41.39 - 41.91
  • 52 Week Range 31.99 - 41.91
  • Volume 9,797,145
  • Avg. Volume 5,957,119
  • Net Assets 6.21B
  • NAV 41.82
  • PE Ratio (TTM) 32.05
  • Yield 3.55%
  • YTD Daily Total Return 6.19%
  • Beta (5Y Monthly) 1.18
  • Expense Ratio (net) 0.09%

Under normal market conditions, the fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Real Estate companies by the Global Industry Classification Standard (GICS®). The fund is non-diversified.

SPDR State Street Global Advisors

Fund Family

Real Estate

Fund Category

6.21B

Net Assets

2015-10-07

Inception Date

Performance Overview: XLRE

View More

Trailing returns as of 8/1/2024. Category is Real Estate.

YTD Return

XLRE
6.19%
Category
1.82%
 

1-Year Return

XLRE
13.69%
Category
5.40%
 

3-Year Return

XLRE
0.09%
Category
2.18%
 

People Also Watch

Holdings: XLRE

View More

Top 10 Holdings (59.96% of Total Assets)

SymbolCompany% Assets
PLD
Prologis, Inc. 10.49%
AMT
American Tower Corporation 9.15%
EQIX
Equinix, Inc. 7.24%
WELL
Welltower Inc. 6.29%
SPG
Simon Property Group, Inc. 4.99%
DLR
Digital Realty Trust, Inc. 4.98%
O
Realty Income Corporation 4.64%
PSA
Public Storage 4.59%
CCI
Crown Castle Inc. 4.28%
EXR
Extra Space Storage Inc. 3.32%

Sector Weightings

SectorXLRE
Real Estate   100.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%
Healthcare   0.00%

Recent News: XLRE

View More

Research Reports: XLRE

View More
  • Biogen Earnings: Shares Undervalued as Cost Controls Materialize and New Launches Accelerate

    Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.

    Rating
    Price Target
     
  • Tesla Earnings: Affordable Vehicle Still on Track for 2025 Launch and 2026 Ramp

    Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi-truck. Tesla also plans to begin selling more affordable vehicles, and a sports car. Global deliveries in 2023 were a little over 1.8 million vehicles. The company also sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.

    Rating
    Price Target
     
  • $105 Fair Value Estimate After Nvidia Completes a 10/1 Split

    Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.

    Rating
    Price Target
     
  • Reaffirming BUY and raising target price to $1,100

    Nvidia Corp., based in Santa Clara, California, is a visual computing company with worldwide operations and markets. The company operates through two segments, Graphics and Compute & Networking. The company's four main markets are gaming, professional visualization, data center, and automotive. In calendar 2020, Nvidia completed the acquisition of data-center connectivity leader Mellanox.

    Rating
    Price Target
     

Related Tickers